Titre : Résultat thérapeutique

Résultat thérapeutique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Résultat thérapeutique : Questions médicales les plus fréquentes", "headline": "Résultat thérapeutique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Résultat thérapeutique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Résultat thérapeutique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Évaluation de résultat (soins)", "url": "https://questionsmedicales.fr/mesh/D017063", "about": { "@type": "MedicalCondition", "name": "Évaluation de résultat (soins)", "code": { "@type": "MedicalCode", "code": "D017063", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Arrêt précoce d'essais cliniques", "alternateName": "Early Termination of Clinical Trials", "url": "https://questionsmedicales.fr/mesh/D057239", "about": { "@type": "MedicalCondition", "name": "Arrêt précoce d'essais cliniques", "code": { "@type": "MedicalCode", "code": "D057239", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.379" } } }, { "@type": "MedicalWebPage", "name": "Évaluation de la réponse des tumeurs solides aux traitements", "alternateName": "Response Evaluation Criteria in Solid Tumors", "url": "https://questionsmedicales.fr/mesh/D066066", "about": { "@type": "MedicalCondition", "name": "Évaluation de la réponse des tumeurs solides aux traitements", "code": { "@type": "MedicalCode", "code": "D066066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.569" } } }, { "@type": "MedicalWebPage", "name": "Réponse virologique soutenue", "alternateName": "Sustained Virologic Response", "url": "https://questionsmedicales.fr/mesh/D000072230", "about": { "@type": "MedicalCondition", "name": "Réponse virologique soutenue", "code": { "@type": "MedicalCode", "code": "D000072230", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.665" } } }, { "@type": "MedicalWebPage", "name": "Index thérapeutique", "alternateName": "Therapeutic Index", "url": "https://questionsmedicales.fr/mesh/D000076162", "about": { "@type": "MedicalCondition", "name": "Index thérapeutique", "code": { "@type": "MedicalCode", "code": "D000076162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.713" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Index thérapeutique du médicament", "alternateName": "Therapeutic Index, Drug", "url": "https://questionsmedicales.fr/mesh/D000074389", "about": { "@type": "MedicalCondition", "name": "Index thérapeutique du médicament", "code": { "@type": "MedicalCode", "code": "D000074389", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.713.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Échec thérapeutique", "alternateName": "Treatment Failure", "url": "https://questionsmedicales.fr/mesh/D017211", "about": { "@type": "MedicalCondition", "name": "Échec thérapeutique", "code": { "@type": "MedicalCode", "code": "D017211", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Échec des secours (soins de santé)", "alternateName": "Failure to Rescue, Health Care", "url": "https://questionsmedicales.fr/mesh/D000067248", "about": { "@type": "MedicalCondition", "name": "Échec des secours (soins de santé)", "code": { "@type": "MedicalCode", "code": "D000067248", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.760.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Résultat thérapeutique", "alternateName": "Treatment Outcome", "code": { "@type": "MedicalCode", "code": "D016896", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Peter S Rose", "url": "https://questionsmedicales.fr/author/Peter%20S%20Rose", "affiliation": { "@type": "Organization", "name": "Clinic Department of Orthopedic Surgery, Rochester, Minnesota, USA." } }, { "@type": "Person", "name": "Matthew T Houdek", "url": "https://questionsmedicales.fr/author/Matthew%20T%20Houdek", "affiliation": { "@type": "Organization", "name": "Clinic Department of Orthopedic Surgery, Rochester, Minnesota, USA." } }, { "@type": "Person", "name": "Pim B Olthof", "url": "https://questionsmedicales.fr/author/Pim%20B%20Olthof", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: p.olthof@erasmusmc.nl." } }, { "@type": "Person", "name": "Stijn Franssen", "url": "https://questionsmedicales.fr/author/Stijn%20Franssen", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Use of surgical bone cement to increase the projection of the nasomaxillary buttress in a case of orthognathic surgery. Technical note.", "datePublished": "2023-05-01", "url": "https://questionsmedicales.fr/article/37214745", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4317/jced.60446" } }, { "@type": "ScholarlyArticle", "name": "Sustainability assessment in construction projects: a sustainable earned value management model under uncertain and unreliable conditions.", "datePublished": "2023-04-30", "url": "https://questionsmedicales.fr/article/37363064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10669-023-09913-2" } }, { "@type": "ScholarlyArticle", "name": "Assessing the effects of climate change on arthropod abundance in Azorean pastures: PASTURCLIM project's baseline monitoring data.", "datePublished": "2023-04-28", "url": "https://questionsmedicales.fr/article/38327350", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3897/BDJ.11.e103723" } }, { "@type": "ScholarlyArticle", "name": "Vortex Veins in Eyes With Pachychoroid Spectrum Disorders Evaluated by the Adjusted Reverse 3-Dimensional Projection Model.", "datePublished": "2023-04-22", "url": "https://questionsmedicales.fr/article/37274011", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.xops.2023.100320" } }, { "@type": "ScholarlyArticle", "name": "Projecting a critique of stigma associated with dementia on screen: The impact of a Canadian film on the importance of relational caring in the community.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37067944", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/geront/gnad045" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Qualité, accès, évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017530" }, { "@type": "ListItem", "position": 3, "name": "Qualité des soins de santé", "item": "https://questionsmedicales.fr/mesh/D011787" }, { "@type": "ListItem", "position": 4, "name": "Mécanismes d'évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017531" }, { "@type": "ListItem", "position": 5, "name": "Évaluation des résultats et des processus en soins de santé", "item": "https://questionsmedicales.fr/mesh/D010043" }, { "@type": "ListItem", "position": 6, "name": "Évaluation de résultat (soins)", "item": "https://questionsmedicales.fr/mesh/D017063" }, { "@type": "ListItem", "position": 7, "name": "Résultat thérapeutique", "item": "https://questionsmedicales.fr/mesh/D016896" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Résultat thérapeutique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Résultat thérapeutique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Résultat thérapeutique", "description": "Comment évaluer l'efficacité d'un traitement ?\nQuels outils mesurent les résultats thérapeutiques ?\nQu'est-ce qu'un critère de jugement ?\nComment les résultats sont-ils rapportés ?\nQuelle est l'importance des études de suivi ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Pilot+Projects&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Résultat thérapeutique", "description": "Quels symptômes indiquent un bon résultat thérapeutique ?\nComment les symptômes peuvent-ils masquer les résultats ?\nLes symptômes peuvent-ils réapparaître après un traitement ?\nComment les symptômes influencent-ils le traitement ?\nQuels sont les symptômes d'une réponse négative au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Pilot+Projects&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Résultat thérapeutique", "description": "Comment prévenir les échecs thérapeutiques ?\nQuel rôle joue l'éducation du patient ?\nLes vaccinations influencent-elles les résultats ?\nComment le mode de vie affecte-t-il les résultats ?\nQuelles sont les stratégies de prévention des complications ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Pilot+Projects&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Résultat thérapeutique", "description": "Quels traitements montrent de bons résultats ?\nComment personnaliser un traitement pour de meilleurs résultats ?\nQuel rôle joue l'adhésion au traitement ?\nLes traitements alternatifs sont-ils efficaces ?\nComment évaluer les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Pilot+Projects&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Résultat thérapeutique", "description": "Quelles complications peuvent survenir après un traitement ?\nComment évaluer les complications d'un traitement ?\nLes complications affectent-elles les résultats ?\nComment prévenir les complications liées au traitement ?\nQuelles sont les complications à long terme des traitements ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Pilot+Projects&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Résultat thérapeutique", "description": "Quels facteurs de risque influencent les résultats ?\nComment les comorbidités affectent-elles les résultats ?\nLe mode de vie influence-t-il les résultats ?\nComment l'âge impacte-t-il les résultats ?\nLes facteurs psychologiques influencent-ils les résultats ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Pilot+Projects&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité d'un traitement ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se mesure par l'amélioration des symptômes et des résultats cliniques." } }, { "@type": "Question", "name": "Quels outils mesurent les résultats thérapeutiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles de mesure, des questionnaires et des biomarqueurs sont utilisés." } }, { "@type": "Question", "name": "Qu'est-ce qu'un critère de jugement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un indicateur utilisé pour évaluer l'efficacité d'un traitement dans les études cliniques." } }, { "@type": "Question", "name": "Comment les résultats sont-ils rapportés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les résultats sont souvent rapportés sous forme de pourcentages d'amélioration ou de scores." } }, { "@type": "Question", "name": "Quelle est l'importance des études de suivi ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'évaluer la durabilité des résultats thérapeutiques sur le long terme." } }, { "@type": "Question", "name": "Quels symptômes indiquent un bon résultat thérapeutique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une réduction des symptômes, comme la douleur ou la fatigue, indique un bon résultat." } }, { "@type": "Question", "name": "Comment les symptômes peuvent-ils masquer les résultats ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes persistants peuvent donner l'impression d'un traitement inefficace, même si des améliorations sont présentes." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils réapparaître après un traitement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains symptômes peuvent réapparaître, nécessitant une réévaluation du traitement." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils le traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes guident les ajustements de traitement pour optimiser les résultats." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une réponse négative au traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une aggravation des symptômes ou l'apparition de nouveaux symptômes peuvent indiquer une réponse négative." } }, { "@type": "Question", "name": "Comment prévenir les échecs thérapeutiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation régulière et des ajustements de traitement peuvent prévenir les échecs." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation du patient ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide les patients à comprendre leur traitement et à améliorer leur adhésion." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les résultats ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent prévenir des complications et améliorer les résultats globaux." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les résultats ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer les résultats thérapeutiques en renforçant la santé globale." } }, { "@type": "Question", "name": "Quelles sont les stratégies de prévention des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les stratégies incluent le suivi régulier, l'éducation et l'adaptation des traitements." } }, { "@type": "Question", "name": "Quels traitements montrent de bons résultats ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements basés sur des preuves, comme les médicaments et la thérapie physique, montrent souvent de bons résultats." } }, { "@type": "Question", "name": "Comment personnaliser un traitement pour de meilleurs résultats ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La personnalisation se fait en tenant compte des caractéristiques individuelles du patient et de sa réponse au traitement." } }, { "@type": "Question", "name": "Quel rôle joue l'adhésion au traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne adhésion au traitement est cruciale pour atteindre des résultats thérapeutiques optimaux." } }, { "@type": "Question", "name": "Les traitements alternatifs sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements alternatifs peuvent être efficaces, mais leur efficacité doit être évaluée scientifiquement." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont évalués par des rapports de patients et des études cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après un traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections ou des effets secondaires peuvent survenir après un traitement." } }, { "@type": "Question", "name": "Comment évaluer les complications d'un traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont évaluées par des examens cliniques et des rapports de patients." } }, { "@type": "Question", "name": "Les complications affectent-elles les résultats ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent altérer les résultats thérapeutiques et nécessiter des ajustements." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au traitement ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un suivi régulier et une gestion proactive des effets secondaires." } }, { "@type": "Question", "name": "Quelles sont les complications à long terme des traitements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent persister, comme des douleurs chroniques ou des troubles fonctionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les résultats ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le sexe et les comorbidités peuvent influencer les résultats thérapeutiques." } }, { "@type": "Question", "name": "Comment les comorbidités affectent-elles les résultats ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les comorbidités peuvent compliquer le traitement et altérer les résultats globaux." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les résultats ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent améliorer les résultats thérapeutiques." } }, { "@type": "Question", "name": "Comment l'âge impacte-t-il les résultats ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut affecter la réponse au traitement et la tolérance aux effets secondaires." } }, { "@type": "Question", "name": "Les facteurs psychologiques influencent-ils les résultats ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le stress et l'anxiété peuvent affecter l'adhésion et les résultats thérapeutiques." } } ] } ] }

Sources (10000 au total)

Assessing the effects of climate change on arthropod abundance in Azorean pastures: PASTURCLIM project's baseline monitoring data.

The data we present are part of the project PASTURCLIM (Impact of climate change on pasture's productivity and nutritional composition in the Azores). The project aims to assess the consequences of cl... We provide an inventory of all arthropods recorded inside OTCs and in control plots in three intensively managed pastures dominated by grasses in Terceira Island (Azores): two of them dominated by rye...

Vortex Veins in Eyes With Pachychoroid Spectrum Disorders Evaluated by the Adjusted Reverse 3-Dimensional Projection Model.

To compare the distribution of vortex vein ampulla (VVA) between pachychoroid spectrum disorder (PSD) and controls.... A single-center, case-control study.... This study included 75 PSD, 35 fellow, and 65 control eyes.... We quantified VVA distribution using a 3-dimensional reverse projection model corrected for image distortion. We investigated the distribution of major drainage veins (MDV), in which macular Haller's ... The mean distances from the optic disc to VVAs and the mean angles between VVAs and the fovea-disc line.... The PSD group had significantly fewer VVA in infranasal sector (PSD, fellow, control; 1.6 ± 0.6, 1.8 ± 0.6, 1.9 ± 0.6, respectively,... The VVA position in supralateral sector was farther and higher in PSD than in controls, suggesting that the distribution of VVA may be associated with the development of PSD.... Proprietary or commercial disclosure may be found after the references....

Projecting a critique of stigma associated with dementia on screen: The impact of a Canadian film on the importance of relational caring in the community.

Relational caring has the capacity to reduce stigma associated with dementia by shifting the focus from dysfunction and behavior management, to attending to the interdependencies and reciprocities tha... We conducted interviews with family carers of people living with dementia and formal care providers affiliated with community-based dementia care, and also the general public at 3 and 8 months post-sc... Our analysis of participants' perceptions/experiences illustrates the effectiveness of Cracked in reducing stigma by demonstrating changes in understandings of dementia and changes in practice. Our an... Our evaluation of Cracked demonstrates that it is an effective strategy for decreasing the stigma associated with dementia by promoting relational caring. It also importantly contributes to the theore...

Education and training in radiation protection in Europe: results from the EURAMED Rocc-n-Roll project survey.

To analyse the existing radiation protection (RP) education and training (E&T) capabilities in the European Union and identify associated needs, problems and challenges.... An online survey was disseminated via the EURAMED Rocc-n-Roll consortium network and prominent medical societies in the field of radiological research. The survey sections analyse the RP E&T during un... The majority of the 550 respondents indicated that RP topics are part of undergraduate curricula in all courses for their profession and country (55%); however, hands-on practical training is not incl... A heterogeneity in RP E&T during undergraduate, residency/internship and continuous professional development is evident across Europe. Differences were noted per area of practice/research, profession,...

Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031.

The aim was to project the health and economic outcomes of cardiovascular disease (CVD) among people with type 2 diabetes from Australian public healthcare and societal perspectives over the next deca... A dynamic multistate model with yearly cycles was developed to project cardiovascular events among Australians with type 2 diabetes aged 40-89 years from 2022 to 2031. CVD risk (myocardial infarction ... Between 2022 and 2031, a total of 83,618 non-fatal MIs (95% uncertainty interval [UI] 83,170-84,053) and 58,774 non-fatal strokes (95% UI 58,458-59,013) were projected. Total years of life lived and Q... CVD in people with type 2 diabetes will substantially impact the Australian healthcare system and society over the next decade. Future work to investigate different strategies to optimize the control ...